A Randomized, Placebo-Controlled Multi-Site Phase 2 Study Evaluation the Safety and Efficacy of Preemptive Treatment With CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation in Adults and Children.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Brincidofovir (Primary)
- Indications Adenovirus infections
- Focus Proof of concept; Therapeutic Use
- Acronyms Adv-Halt
- Sponsors Chimerix
- 09 Sep 2014 Results presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 08 Sep 2014 Results published in the Media Release.
- 04 Nov 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History